* [Rivers et al](https://www.nejm.org/doi/full/10.1056/nejmoa010307) (2001)
	* Single-centre, non-randomised, non-blinded trial
	* High control group mortality (46.5%)
	* Significant hospital â†“ mortality in EGDT arm (30% vs. 46%)
	* Use of ScvO~2~ target was not based on prior evidence
	* Effect may be due to presence of experience clinician at the bedside directing therapy